Alejandro de Feria

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy”.

Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy

Cardiology and Therapy(2022)10.1007/s40119-022-00283-5

N/A

0DataRank · unranked

30 citations

Alejandro de Feria, Supriya Peshin, Nosheen Reza, Anjali Owens, Elizabeth Packard

Cardiovascular Characteristics of Patients with Genetic Variation in Desmoplakin (DSP)

Cardiogenetics(2022)10.3390/cardiogenetics12010003

N/A

0DataRank · unranked

14 citations

Alejandro de Feria, Jessica L. Chowns, Lily Hoffman‐Andrews, Laura Vann, Jessica Kim +3 more

Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten

JACC Heart Failure(2024)10.1016/j.jchf.2024.03.009

N/A

0DataRank · unranked

16 citations

Anandkumar Dubey, Thomas Carattini, Amy Marzolf, Nicole Hornsby, Alejandro de Feria +4 more

Long-Term Real-World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks

Journal of Clinical Medicine(2025)10.3390/jcm14228181

N/A

0DataRank · unranked

3 citations

Anandkumar Dubey, Nadim Mahmud, Melissa A. Austin, Estherland Duqueney, Parth Patel +8 more